ATE339510T1 - Dna-konstrukt zur gewebespezifischen expression eines blutkgerinnungsfaktors - Google Patents

Dna-konstrukt zur gewebespezifischen expression eines blutkgerinnungsfaktors

Info

Publication number
ATE339510T1
ATE339510T1 AT00107616T AT00107616T ATE339510T1 AT E339510 T1 ATE339510 T1 AT E339510T1 AT 00107616 T AT00107616 T AT 00107616T AT 00107616 T AT00107616 T AT 00107616T AT E339510 T1 ATE339510 T1 AT E339510T1
Authority
AT
Austria
Prior art keywords
tissue
specific expression
dna construct
blood clotting
clotting factor
Prior art date
Application number
AT00107616T
Other languages
English (en)
Inventor
Claude Dr Negrier
Marie Helene Rodriguez
Nathalie Enjolras
Original Assignee
Zlb Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zlb Behring Gmbh filed Critical Zlb Behring Gmbh
Application granted granted Critical
Publication of ATE339510T1 publication Critical patent/ATE339510T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00107616T 1999-04-27 2000-04-08 Dna-konstrukt zur gewebespezifischen expression eines blutkgerinnungsfaktors ATE339510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99107397A EP1048736A1 (de) 1999-04-27 1999-04-27 DNA-Konstrukt für die Gewebespezifischen Expression eines Blutkoagulationsfaktors

Publications (1)

Publication Number Publication Date
ATE339510T1 true ATE339510T1 (de) 2006-10-15

Family

ID=8237961

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00107616T ATE339510T1 (de) 1999-04-27 2000-04-08 Dna-konstrukt zur gewebespezifischen expression eines blutkgerinnungsfaktors

Country Status (11)

Country Link
US (1) US6884616B1 (de)
EP (2) EP1048736A1 (de)
JP (1) JP4373578B2 (de)
KR (1) KR100681719B1 (de)
AT (1) ATE339510T1 (de)
AU (1) AU779437B2 (de)
CA (1) CA2304376C (de)
DE (1) DE60030621T2 (de)
DK (1) DK1048726T3 (de)
ES (1) ES2270758T3 (de)
PT (1) PT1048726E (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE489105T1 (de) 2004-03-19 2010-12-15 Baxter Int Faktor ixa zur behandlung von blutungsstörungen
CA2715080C (en) 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
CA2724630A1 (en) 2008-05-16 2009-11-19 Bayer Healthcare Llc Targeted coagulation factors and method of using the same
CA2888982C (en) * 2012-10-24 2020-07-21 Platelet Targeted Therapeutics, Llc Platelet targeted treatment
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
US10842885B2 (en) 2018-08-20 2020-11-24 Ucl Business Ltd Factor IX encoding nucleotides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678282B1 (fr) 1991-06-28 1994-08-26 Commissariat Energie Atomique Sequences amplificateur et silenceur isolees du promoteur de la gpiib, et leurs applications.
JPH08511423A (ja) * 1993-06-10 1996-12-03 ジェネティック セラピー，インコーポレイテッド 血友病治療のためのアデノウイルスベクター
US6066778A (en) * 1996-11-06 2000-05-23 The Regents Of The University Of Michigan Transgenic mice expressing APC resistant factor V
FR2763959A1 (fr) * 1997-06-02 1998-12-04 Transgene Sa Nouveaux vecteurs adenoviraux recombinants comprenant une sequence d'epissage

Also Published As

Publication number Publication date
KR20010020795A (ko) 2001-03-15
US6884616B1 (en) 2005-04-26
JP4373578B2 (ja) 2009-11-25
KR100681719B1 (ko) 2007-02-15
PT1048726E (pt) 2006-12-29
DK1048726T3 (da) 2006-11-20
ES2270758T3 (es) 2007-04-16
DE60030621T2 (de) 2007-09-27
CA2304376C (en) 2010-06-01
DE60030621D1 (de) 2006-10-26
JP2000333687A (ja) 2000-12-05
AU3019500A (en) 2000-11-02
EP1048735A1 (de) 2000-11-02
EP1048736A1 (de) 2000-11-02
EP1048735B1 (de) 2006-09-13
AU779437B2 (en) 2005-01-27
CA2304376A1 (en) 2000-10-29

Similar Documents

Publication Publication Date Title
DE69805772D1 (de) Stabilisierte mischung auf fibrinogenbasis
DK1100880T3 (da) Urat oxidase
ATE199938T1 (de) Adenovirus-aav zwittervirus sowieverfahrungen zur verwendung davon
DE605477T1 (de) Gasförmige ultraschallkontrastmittel und verfahren zur auswahl von gasen für die verwendung als ultraschallkontrastmittel.
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
HK1060902A1 (en) Removal of plasmin (ogen) from protein solutions
WO2004024300A8 (en) Ultrafiltration membrane, device, bioartificial organ and methods
DE60311731D1 (de) Verfahren zur rekombinanten Herstellung von Antifusogenikpeptide
NO981044L (no) Sirkulært DNA-molekyl med kondisjonell replikasjonsopprinnelse, dets fremstilling og anvendelse derav i genterapi
DE69725861D1 (de) Katalytische nukleinsäuren und deren medizinische verwendung
AU4691589A (en) Feline infectious peritonitis virus diagnostic tools
DE60207490D1 (de) Verfahren zur Herstellung von (Meth)Acrylsäureanhydrid
DE60030621D1 (de) DNA-Konstrukt zur gewebespezifischen Expression eines Blutkgerinnungsfaktors
DK0969877T3 (da) Fremgangsmåder til modulering af væksten af collaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE60220281D1 (de) Verfahren zur herstellung von reduziertem coenzym q10
DK1205542T3 (da) L-aminosyre-oxidase fra Rhodococcus arter
ATE512217T1 (de) 5-substituerte hydantoin racemase, dafür kodierende dna, und verfahren zur herstellung optisch aktiver aminosäure
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
ATE286746T1 (de) Proteinhaltige hydrogele
ATE205529T1 (de) Reninaktive substanz enthaltend humanes prorenin und antikörper gegen das prorenin profragment
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
FR2846004B1 (fr) Composition pour culture de cellules notamment animales ou de tissus, comprenant du polyethylene glycol
DE59802825D1 (de) Verfahren zur Herstellung von 4-Nitro-2-sulfo-benzoesäure
ATE288476T1 (de) Herstellung von proteinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1048735

Country of ref document: EP

EEFA Change of the company name